In this context, SOCS1-deficient HCC cells, which upregulate NRF2-mediated and possibly other antioxidant defense mechanisms, could be rendered susceptible to chemotherapeutic agents that increase ROS production if their elevated antioxidant mechanisms could be simultaneously suppressed. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.